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Total anomalous pulmonary vein connection (TAPVC), one of the
iseases with extremely poor prognosis, is deﬁned as the anomaly
hich the pulmonary veins have no connection with the left atrium
ut rather connect directly to one of the systemic veins or drain into
he right atrium. The frequency of TAPVC is reported from 5.9 to 7.1
er 100,000 live births.
Independent risk factors for death of this anomaly from an
nternational study comprised of earlier age at surgery, hypoplas-
ic/stenotic pulmonary veins, associated complex cardiac lesions,
ostoperative pulmonary hypertension, and postoperative pul-
onary vein obstruction [1]. The existence of obstructed lesion
s the most critical for determining prognosis of this anomaly.
n infant with obstructive TAPVC usually is acutely plunged
nto marked respiratory distress, cyanosis, and metabolic acido-
is. Therefore, immediate relief of the obstruction is required and
orrective surgery should be performed as soon as possible for this
omplicated cardiac anomaly as a basic idea.
Although intrinsic narrowing in the walls of the anomalous ves-
els occurs, extrinsic pressure frequently results in narrowing of
he venous structure. The vertical vein in TAPVC to the innomi-
ate vein may  be compressed between the left main pulmonary
rtery and left main bronchus. Similarly, the anomalous pulmonary
ein in TAPVC to the SVC may  be obstructed by the right pul-
onary artery and trachea. Balloon dilation of extrinsic obstructed
nomalous venous channels may  be unsuccessful as Lock et al. [2]
escribed. When the anomalous connection is to the portal vein, the
epatic sinusoids are interposed in the pulmonary venous chan-
el and result in increased resistance to pulmonary venous return.
nother factor that may  contribute to impedance of pulmonary
enous return is the length of the ascending or descending verti-
al venous pathway. Almost all these situation in infracardiac type
APVC are hardly any candidates of catheter interventions.
On the other hand, it can be said that the many cases of TAPVC
ave obstruction mainly at the position where catheter interven-
ion can be performed relatively with ease, because pulmonary
enous obstruction is known to present in about 50% of suprac-
rdiac type [3]. As this report by Matsui et al. [4], the obstructed
ortions of the supracardiac type are usually approached from the
nternal jugular vein with ease.
DOI of original article: http://dx.doi.org/10.1016/j.jccase.2013.04.001.
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ttp://dx.doi.org/10.1016/j.jccase.2013.05.001In general, pulmonary venous angioplasty (class IIa) or stenting
(class IIb) should be considered after surgical repair for TAPVC as an
evidence level of C. In the American Heart Association (AHA) rec-
ommendation, pulmonary venous angioplasty and stenting should
not be considered in the management of pulmonary vein steno-
sis associated with other congenital heart diseases that requires
surgical intervention (class III) under the evidence level of C [5].
However, the idea of preoperative stabilization by temporarily
relieving the obstruction is emerged recently to improve outcomes
for neonatal obstructed TAPVR. Moreover, in the low birth weight
neonate, percutaneous balloon angioplasty or stent placement
maybe the only therapeutic options [6]. Palliative stent placement
in obstructed TAPVC was  technically feasible and efﬁcacious in
relieving pulmonary venous obstruction in low birth weight infant.
Review of literature suggests that stent placement in obstructed
TAPVC adequately improves obstruction and may  be an effective
temporizing measure prior to surgical repair in a more favor-
able clinical status [7,8]. Although AHA statement does not refer
the management against native obstructed TAPVC, the guideline
edited by Japanese Pediatric Inteventional Cardiaology (JPIC) added
another comment as class III that, in the severe cases of obstruc-
tive TAPVC with complex cardiac anomaly, the pulmonary venous
stenting may  be allowed to avoid early surgical intervention which
results in a very poor outcome as the evidence level of C [9].
Stent implantations were acutely effective in the focal relief
of stenosis, with few procedural complications. However, stent
obstruction and reintervention were common. Thus, stent implan-
tation appears to serve a primarily palliative purpose in most
patients with pulmonary vein stenosis [10]. Previous reports have
suggested that stent diameter was required at least around 6–7 mm
for prolonged freedom from restenosis in case of using bare metal
stents [10]. It is thought that early restenosis is common after bare
metal stent implantation for obstructive TAPVC in small babies who
have vertical veins of much smaller than 9 mm in diameter. There-
fore, when one uses bare metal coronary stent for obstructed lesion
of neonatal pulmonary vein such as a Multi-Link VISION coronary
stent Matsui et al. applied, restenosis must be recognized to occur
within a short period.
Although the drug-eluting stent (DES) against obstructed
TAPVR has been reported effectiveness for prevention of restenosis
[11], limitation of the size of DES no larger than around 5 mm could
not realize effective dilatation of stenotic lesion of pulmonary
veins [9]. However, the issue of restenosis may  be ignorable for
bare-metal stenting to the obstructed TAPVR because stenting
against this lesion must be basically alternative and bridging use
in a neonatal period.
The obstructed TAPVR is frequently required urgent surgical
intervention to neonates under critical conditions. It is obvious, as
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he authors mentioned, that surgical intervention with cardiopul-
onary bypass for critical patients is an inducer of worsening
ulmonary edema, intracranial hemorrhage, and organ ischemia.
lthough the patient in this article was undertaken urgent stenting
or releasing obstruction of pulmonary vein tract, the procedures
he authors shown was safe as far as under well disciplined team.
his provides that the stent implantation for obstructed TAPVR
as possibility as the ﬁrst choice treatment against neonates under
xtremely critical conditions.
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